Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Elecoglipron

Embold

AstraZeneca · Phase 3 · Recruiting · Enrollment 4500

NCT07667803

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Arm 1 - Dose 1n/rn/rn/rn/r
Arm 2 - Dose 2n/rn/rn/rn/r
Arm 3 - Placebon/rn/rn/rn/r

Not shown

  • Arm 1 - Dose 1: endpoint not reported
  • Arm 2 - Dose 2: endpoint not reported
  • Arm 3 - Placebo: endpoint not reported